Clinical Trial Update: Mild Encephalopathy in the Newborn Treated With Darbepoetin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated darbepoetin for mild encephalopathy in newborns, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy Mild
• Neonatal Encephalopathy

Drugs mentioned

• Darbepoetin (darbepoetin alfa)

Snippet

Sponsor: University of New Mexico | Conditions: Neonatal Encephalopathy, Hypoxic-Ischemic Encephalopathy Mild | Phase 2 | Status: COMPLETED | Results posted: 2023-07-25